Alliance Pharmaceutical Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Alliance Pharmaceutical

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John R Resseger who wrote (327)	1/18/1999 2:35:00 PM
From: Cacaito	of 548

Baxter, blood substitutes, lack of consent, and FDA problems: infobeat.com I always wonder why did ALLP went for the blood substitute in the heart surgery scenario, now is clear, the informed consent legal and ethical problems are a big constrain to this type of research. In Allp case the surgery is elective and their is plenty of time to inform the patients and to obtain consent. In the Baxter model, the ER is an acute setting patients are dying and there is no time for information and/or consent. Most of the time, family members are the consent providers.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next